Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin E Longbrake

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis and Related Disorders|December 22, 2022
Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic diseaseJohn Peters, Erin E Longbrake
Nature Reviews. Neuroscience|May 21, 2008
Can the immune system be harnessed to repair the CNS?Phillip G Popovich, Erin E Longbrake
Current Opinion in Neurology|March 28, 2024
Shifting our attention earlier in the multiple sclerosis disease courseSamantha E Epstein, Erin E Longbrake
JAMA Neurology|January 1, 2016
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral ImmunityErin E Longbrake, Anne H Cross
Cell|January 18, 2020
Siponimod Chips Away at Progressive MSErin E Longbrake, David A Hafler
Expert Review of Neurotherapeutics|March 11, 2009
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?Erin E Longbrake, Michael K Racke
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 11, 2017
Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practiceErin E Longbrake, Anne H Cross, Amber Salter
Translational Research : the Journal of Laboratory and Clinical Medicine|January 30, 2021
Influence of immunomodulatory drugs on the gut microbiotaInessa Cohen, William E Ruff, Erin E Longbrake
Multiple Sclerosis and Related Disorders|March 11, 2022
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medicationsElle Levit, Erin E Longbrake, Sharon S Stoll
Current Neurology and Neuroscience Reports|September 13, 2013
Monoclonal antibodies as disease modifying therapy in multiple sclerosisErin E Longbrake, Becky J Parks, Anne H Cross
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis and Related Disorders|December 22, 2022
Infection risk in a real-world cohort of patients treated with long-term B-cell depletion for autoimmune neurologic diseaseJohn Peters, Erin E Longbrake
Nature Reviews. Neuroscience|May 21, 2008
Can the immune system be harnessed to repair the CNS?Phillip G Popovich, Erin E Longbrake
Current Opinion in Neurology|March 28, 2024
Shifting our attention earlier in the multiple sclerosis disease courseSamantha E Epstein, Erin E Longbrake
JAMA Neurology|January 1, 2016
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral ImmunityErin E Longbrake, Anne H Cross
Cell|January 18, 2020
Siponimod Chips Away at Progressive MSErin E Longbrake, David A Hafler
Expert Review of Neurotherapeutics|March 11, 2009
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?Erin E Longbrake, Michael K Racke
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 11, 2017
Efficacy and tolerability of oral versus injectable disease-modifying therapies for multiple sclerosis in clinical practiceErin E Longbrake, Anne H Cross, Amber Salter
Translational Research : the Journal of Laboratory and Clinical Medicine|January 30, 2021
Influence of immunomodulatory drugs on the gut microbiotaInessa Cohen, William E Ruff, Erin E Longbrake
Multiple Sclerosis and Related Disorders|March 11, 2022
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medicationsElle Levit, Erin E Longbrake, Sharon S Stoll
Current Neurology and Neuroscience Reports|September 13, 2013
Monoclonal antibodies as disease modifying therapy in multiple sclerosisErin E Longbrake, Becky J Parks, Anne H Cross
Pageof 9